NVRS.CN · 2026-07-17 21:35:00

Noveris Health Sciences Joins the Biotechnology Innovation Organization (BIO)

VANCOUVER, BC, Canada – TheNewswire - July 17, 2026 — Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) (“Noveris” or the “Company”) is pleased to announce that it has joined the Biotechnology Innovation Organization (“BIO”), the world's largest advocacy association representing biotechnology companies, academic and research institutions, state and regional biotechnology centers and related organizations across the United States and in more than 35 other countries.

By joining BIO, Noveris is strengthening its participation in the global biotechnology ecosystem and expanding opportunities to engage with industry leaders, strategic partners, investors and policymakers across the United States and internationally. The Company believes that membership in BIO will support greater visibility for Noveris within the broader biotechnology and life sciences community while providing access to BIO's policy committees, investor and partnering events, industry research and cost-savings programs that help foster collaboration and commercialization.

“Joining BIO reflects our commitment to being an active participant in the global biotechnology industry,” said Jason Birmingham, President & Chief Executive Officer of Noveris. “We see meaningful value in aligning with an organization that brings together leading biotechnology companies, investors and policymakers from around the world, and we look forward to contributing to and benefiting from the BIO community as we continue to advance Noveris' strategic priorities.”

BIO serves as a key industry platform connecting biotechnology companies, researchers, institutions and capital providers, and Noveris expects its membership to enhance the Company's profile within the broader healthcare and biotechnology landscape. The Company also anticipates participation in BIO events, including the BIO International Convention, along with member programming, policy committees and partnering initiatives that can help support relationship-building, knowledge-sharing and long-term strategic development.

About Noveris Health Sciences Inc.

Noveris Health Sciences Inc. is a biotechnology company focused on the development, advancement and commercialization of healthcare technologies and opportunities addressing unmet needs in the market. The Company’s common shares trade on the Canadian Securities Exchange under the symbol NVRS, on the Frankfurt Stock Exchange under the symbol 0NF0, and on the OTC market under the symbol MYCOF.

For more information, visit www.noveris.health.

About the Biotechnology Innovation Organization

The Biotechnology Innovation Organization (BIO) is the world's largest advocacy association representing biotechnology companies, academic and research institutions, state biotechnology centers and related organizations across the United States and in more than 35 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also organizes the BIO International Convention, the world's largest gathering of the biotechnology industry, along with a series of investor and partnering meetings held around the world.

For further information:

Noveris Health Sciences Inc.
Jason Birmingham
President & Chief Executive Officer
Telephone: +1 (778) 900-6877
Email: [email protected]
Website: www.noveris.health

Forward-Looking Statements

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Forward-looking statements in this news release include, but are not limited to, statements regarding the anticipated benefits of the Company's membership in BIO, including increased visibility, collaboration opportunities, stakeholder engagement, participation in events and programming, and support for the Company's strategic development and commercialization objectives. Forward-looking statements are often identified by words such as “expects,” “believes,” “will,” “anticipates,” “plans,” and similar expressions, or statements that certain actions, events or results “may,” “could,” or “should” occur.

These forward-looking statements are based on management’s current expectations, assumptions and beliefs as of the date of this news release and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties may include, without limitation, changes in business, market, economic or regulatory conditions, the Company’s ability to realize the expected benefits of its BIO membership, and other risks associated with the Company’s business and operations.

Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law.

← Back to feed